Detailed Information on Publication Record
2023
Predictive factors of multiple sclerosis relapse after the first demyelinating event: A 5-year follow-up
KOLČAVA, Jan, Ondřej PELÍŠEK and Eva VLČKOVÁBasic information
Original name
Predictive factors of multiple sclerosis relapse after the first demyelinating event: A 5-year follow-up
Authors
KOLČAVA, Jan (203 Czech Republic, belonging to the institution), Ondřej PELÍŠEK (203 Czech Republic, belonging to the institution) and Eva VLČKOVÁ (203 Czech Republic, guarantor, belonging to the institution)
Edition
MULTIPLE SCLEROSIS AND RELATED DISORDERS, OXFORD, ELSEVIER SCI LTD, 2023, 2211-0348
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30210 Clinical neurology
Country of publisher
United Kingdom of Great Britain and Northern Ireland
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 4.000 in 2022
RIV identification code
RIV/00216224:14110/23:00130653
Organization unit
Faculty of Medicine
UT WoS
000940954500001
Keywords in English
Clinically isolated syndrome; Magnetic resonance imaging; Multiple sclerosis; Oligoclonal bands; Demyelinating diseases
Tags
International impact, Reviewed
Změněno: 27/4/2023 09:44, Mgr. Tereza Miškechová
Abstract
V originále
There is a growing need to discover the characteristics that predict prognostic factors after the first demyelin-ating event. In this study of 141 patients that met the 2017 McDonald criteria, a higher number of oligoclonal bands, cervical spinal cord demyelinating lesions, and sensory involvement were identified as independent predictors of the second demyelinating event during the 5-year follow-up period in patients who experienced the first demyelinating event. The identification of the aforementioned risk variables will make it possible to identify patients who are more likely to exhibit early second demyelinating event, implying more frequent monitoring and consideration of early application of highly effective disease-modifying treatment.
Links
MUNI/A/1186/2022, interní kód MU |
|